Resurgence of COVID-19 in Manaus, Brazil, despite high seroprevalence - PubMed (original) (raw)
. 2021 Feb 6;397(10273):452-455.
doi: 10.1016/S0140-6736(21)00183-5. Epub 2021 Jan 27.
Lewis F Buss 2, Maria P S Carvalho 3, Carlos A Prete Jr 4, Myuki A E Crispim 3, Nelson A Fraiji 3, Rafael H M Pereira 5, Kris V Parag 6, Pedro da Silva Peixoto 7, Moritz U G Kraemer 8, Marcio K Oikawa 9, Tassila Salomon 10, Zulma M Cucunuba 6, Márcia C Castro 11, Andreza Aruska de Souza Santos 12, Vítor H Nascimento 4, Henrique S Pereira 13, Neil M Ferguson 6, Oliver G Pybus 8, Adam Kucharski 14, Michael P Busch 15, Christopher Dye 8, Nuno R Faria 16
Affiliations
- PMID: 33515491
- PMCID: PMC7906746
- DOI: 10.1016/S0140-6736(21)00183-5
Resurgence of COVID-19 in Manaus, Brazil, despite high seroprevalence
Ester C Sabino et al. Lancet. 2021.
No abstract available
Figures
Figure
COVID-19 hospitalisations, excess deaths, and Rt in Manaus, Brazil, 2020–21 (A) Dark lines are the 7-day rolling averages and lighter lines are the daily time series of COVID-19 hospitalisations and excess deaths. Hospitalisation data are from the Fundação de Vigilância em Saúde do Amazonas. Total all-cause deaths for 2020–21 were reported initially by the Prefeitura de Manaus and subsequently in the daily COVID-19 bulletin of the Fundação de Vigilância em Saúde do Amazonas. All-cause deaths from 2019 were from Arpen/AM (Associação dos Registradores Civis das Pessoas Naturais do Amazonas). The compiled excess death data are from Bruce Nelson from the Instituto Nacional de Pesquisas da Amazônia. (B) _R_t was calculated using the time series of COVID-19 hospitalisations after removal of the past 14 days to account for delays in notification. _R_t was calculated using the EpiFilter method. Lines are median _R_t estimates; shaded areas are the 95% CIs. _R_t=Effective reproduction number. SARS-CoV-2=severe acute respiratory syndrome coronavirus 2.
Similar articles
- SARS-CoV-2 seroprevalence and associated factors in Manaus, Brazil: baseline results from the DETECTCoV-19 cohort study.
Lalwani P, Salgado BB, Filho IVP, da Silva DSS, de Morais TBDN, Jordão MF, Barbosa ARC, Cordeiro IB, Neto JNS, de Assunção EN, Dos Santos RO, Carvalho NO, Sobrinho WBS, da Costa CF, de Souza PE, de Albuquerque BC, Ganoza CA, Araujo-Castillo RV, Filho SA, Lalwani JDB; DETECTCoV-19 Study Team. Lalwani P, et al. Int J Infect Dis. 2021 Sep;110:141-150. doi: 10.1016/j.ijid.2021.07.017. Epub 2021 Jul 14. Int J Infect Dis. 2021. PMID: 34273518 Free PMC article. - High anti-SARS-CoV-2 antibody seroconversion rates before the second wave in Manaus, Brazil, and the protective effect of social behaviour measures: results from the prospective DETECTCoV-19 cohort.
Lalwani P, Araujo-Castillo RV, Ganoza CA, Salgado BB, Pereira Filho IV, da Silva DSS, de Morais TBDN, Jordão MF, Ortiz JV, Barbosa ARC, Sobrinho WBS, Cordeiro IB, de Souza Neto JN, de Assunção EN, da Costa CF, de Souza PE, de Albuquerque BC, Astofi-Filho S; DETECTCoV-19 Study Team; Lalwani JDB. Lalwani P, et al. Lancet Glob Health. 2021 Nov;9(11):e1508-e1516. doi: 10.1016/S2214-109X(21)00355-7. Lancet Glob Health. 2021. PMID: 34678195 Free PMC article. - Seroprevalence of SARS-CoV-2 antibodies in the poorest region of Brazil: results from a population-based study.
de Souza Araújo AA, Quintans-Júnior LJ, Heimfarth L, Schimieguel DM, Corrêa CB, de Moura TR, Cavalcante RCM, Rodrigues Bomfim R, Grespan R, Santana Rodrigues L, Dos Santos DM, de Sá Resende A, de Lima Silva N, da Silva Santos ACR, Dantas Araújo JM, de Souza MF, de Oliveira Góes MA, Santana Santos V, Martins-Filho PR. de Souza Araújo AA, et al. Epidemiol Infect. 2021 May 18;149:e130. doi: 10.1017/S0950268821001163. Epidemiol Infect. 2021. PMID: 34001292 Free PMC article. - COVID-19 seroprevalence in military police force, Southern Brazil.
Pasqualotto AC, Pereira PC, Lana DFD, Schwarzbold AV, Ribeiro MS, Riche CVW, Castro CPP, Korsack PL, Ferreira PEB, Domingues GC, Ribeiro GT, Carneiro M, Caurio CFB, Vasconcellos ICDS, Knebel LM, Zamberlan L, Stolz AP, Vilanova M, Watte G, Kalil AN. Pasqualotto AC, et al. PLoS One. 2021 Apr 22;16(4):e0249672. doi: 10.1371/journal.pone.0249672. eCollection 2021. PLoS One. 2021. PMID: 33886596 Free PMC article. - Seroprevalence Brazil.
Fialho PMM, Correa CRS, Lescano SZ. Fialho PMM, et al. Adv Parasitol. 2020;109:357-374. doi: 10.1016/bs.apar.2020.01.013. Epub 2020 Jan 31. Adv Parasitol. 2020. PMID: 32381207 Review.
Cited by
- The role of convalescent plasma and hyperimmune immunoglobulins in the COVID-19 pandemic, including implications for future preparedness.
So-Osman C, Burnouf T, Al-Riyami AZ, Bloch EM, Estcourt L, Goel R, Tiberghien P, Vermeulen M, Wendel S, Wood EM. So-Osman C, et al. Front Immunol. 2024 Sep 9;15:1448720. doi: 10.3389/fimmu.2024.1448720. eCollection 2024. Front Immunol. 2024. PMID: 39315108 Free PMC article. Review. - A Comparative Analysis of SARS-CoV-2 Variants of Concern (VOC) Spike Proteins Interacting with hACE2 Enzyme.
Chen J, Chen L, Quan H, Lee S, Khan KF, Xie Y, Li Q, Valero M, Dai Z, Xie Y. Chen J, et al. Int J Mol Sci. 2024 Jul 23;25(15):8032. doi: 10.3390/ijms25158032. Int J Mol Sci. 2024. PMID: 39125601 Free PMC article. - Impact of Gamma COVID-19 variant on the prognosis of hospitalized pregnant and postpartum women with cardiovascular disease.
Testa CB, de Godoi LG, Monroy NAJ, Bortolotto MRFL, Rodrigues AS, Francisco RPV. Testa CB, et al. Clinics (Sao Paulo). 2024 Aug 8;79:100454. doi: 10.1016/j.clinsp.2024.100454. eCollection 2024. Clinics (Sao Paulo). 2024. PMID: 39121513 Free PMC article. - The Protective Efficacy of a SARS-CoV-2 Vaccine Candidate B.1.351V against Several Variant Challenges in K18-hACE2 Mice.
Yang J, Fan H, Yang A, Wang W, Wan X, Lin F, Yang D, Wu J, Wang K, Li W, Cai Q, You L, Pang D, Lu J, Guo C, Shi J, Sun Y, Li X, Duan K, Shen S, Meng S, Guo J, Wang Z. Yang J, et al. Vaccines (Basel). 2024 Jul 3;12(7):742. doi: 10.3390/vaccines12070742. Vaccines (Basel). 2024. PMID: 39066379 Free PMC article. - Impact of the first year of COVID-19 vaccination strategy in Brazil: an ecological study.
Aguilar S, Bastos LSL, Maçaira P, Baião F, Simões P, Cerbino-Neto J, Ranzani O, Hamacher S, Bozza FA. Aguilar S, et al. BMJ Open. 2024 Jul 4;14(7):e072314. doi: 10.1136/bmjopen-2023-072314. BMJ Open. 2024. PMID: 38964793 Free PMC article.
References
- Fundação de Vigilância em Saúde do Amazonas COVID-19 no Amazonas. Dados epidemiológicos e financeiros das ações de combate à COVID-19. Publicações. http://www.fvs.am.gov.br/publicacoes
Publication types
MeSH terms
Grants and funding
- MC_PC_19012/MRC_/Medical Research Council/United Kingdom
- MR/S019510/1/MRC_/Medical Research Council/United Kingdom
- 206250/Z/17/Z/WT_/Wellcome Trust/United Kingdom
- WT_/Wellcome Trust/United Kingdom
- MR/R024855/1/MRC_/Medical Research Council/United Kingdom
- MR/R015600/1/MRC_/Medical Research Council/United Kingdom
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical